no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
Garner has aggregated claims data on 320M patients to score every US doctor on quality and cost, then steers employer-plan demand toward top performers via financial incentives. The data moat plus financial workflow lock-in (not foundation-model-replicable) underpins a Series E at a ~$2.7B valuation led by Index Ventures, a large step-up while doubling-to-tripling revenue annually.